ONL Therapeutics

About:

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

Website: http://www.onltherapeutics.com/

Twitter/X: onltherapeutics

Top Investors: Novartis, National Institutes of Health, Biosciences Research and Commercialization Center (BRCC), Novartis Venture Fund, Johnson & Johnson Innovation – JJDC

Description:

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. It was founded in 2011 and is headquartered in Ann Arbor, Michigan.

Total Funding Amount:

$148M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)onltherapeutics.com

Founders:

David Zacks

Number of Employees:

11-50

Last Funding Date:

2024-09-13

IPO Status:

Private

Industries: